Abstract B023: Identifying therapeutic vulnerabilities in metastatic prostate cancer transcriptional phenotypes
David A. Gallo(University of Wisconsin Carbone Cancer Center), Marina N. Sharifi(University of Wisconsin–Madison), Kyle T. Helzer(University of Wisconsin–Madison), Mashooq Ahmad Dar(University of Wisconsin–Madison), Jamie M. Sperger(University of Wisconsin–Madison), Grace C. Blitzer(University of Wisconsin–Madison), Amy K. Taylor(University of Wisconsin–Madison), Matthew L. Bootsma(University of Wisconsin–Madison), David Kosoff(University of Wisconsin–Madison), John M. Floberg(University of Wisconsin–Madison), Joshua M. Lang(University of Wisconsin–Madison), Charlotte Linebarger(University of Wisconsin–Madison), Alex H. Chang(University of Wisconsin–Madison), William M. Stump(University of Wisconsin–Madison), Wei X. Xiao(Dana-Farber Cancer Institute), Viridiana Carreno(University of Wisconsin–Madison), Kristen Rosche(University of Wisconsin–Madison), Rana R. McKay(University of California San Diego), Kaitlin Durnen(University of Wisconsin–Madison), Shuang G. Zhao(University of Wisconsin–Madison), Emily Abella(University of Wisconsin Carbone Cancer Center), Kendra D. Marr(University of Arizona)
Cited by 0
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors
|Proceedings of the National Academy of Sciences|2003|650
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021
|Journal of the National Comprehensive Cancer Network|2021|532